Managed Care Executives

Study of 1.8 billion doctor visits showed no real advantage over paper files

What to watch—and watch out for—in the bottom half of '07

New vaccines can be good business and a huge boon to public health. But the challenge is to establish prices that ensure global access.

What works best in drugs, devices, biologicals, and procedures

To succeed as a leader, you need purpose, performance, persistence, passion, and much more. But some of the top figures in industry give credit to another factor: providence.

This continuing education lesson reviews the new molecular entities (NMEs) approved by the Food & Drug Administration in 2006.

Legislation to mandate government negotiation on Medicare Part D drug prices has now passed the U.S. House of Representatives

More than 1.6 million physicians, pharmacists, and healthcare companies have registered for the new National Provider Identifier (NPI) numbers

...proposed rule governing Medicaid reimbursement that would cut more than $8 billion in Medicaid generic drug reimbursements over...